Clinical Efficacy and Safety of Combined House Dust mite Subcutaneous Immunotherapy and Omalizumab in Five Cases of Allergic Rhinitis and Asthma

Allergen immunotherapy (AIT) is a well-recognized treatment for altering the natural course of respiratory allergy which builds immune tolerance and prevents progression of allergic diseases. In our five cases of house dust mite (HDM)-driven allergic rhinitis and asthma, combined HDM Subcutaneous Im...

Full description

Saved in:
Bibliographic Details
Main Authors: P.C. Kathuria, Manisha Rai
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-07-01
Series:Indian Journal of Medical Specialities
Subjects:
Online Access:https://journals.lww.com/10.4103/injms.injms_7_21
Tags: Add Tag
No Tags, Be the first to tag this record!